
News from CNIO
Top CNIO News

France · FranceA decade after the first steps of virotherapy, the medical world goes further. Scientists have succeeded in transforming the herpes virus into a formidable weapon against cancer. A phase 1/2 clinical trial has just proved this: the RP1, a genetically modified herpes simplex virus, has succeeded in reducing advanced melanoma tumours, even deeply rooted in the body. A discovery that could well change the deal for thousands of patients.See the Story